Table Of Contents

1. Introduction

1.1 Market Definition & Scope

1.2 Research Assumptions & Abbreviations

1.3 Research Methodology

2. Executive Summary

 2.1 Market Snapshot

 2.2 Market Absolute $ Opportunity Assessment & Y-o-Y Analysis, 2022–2035

 2.3 Market Size & Forecast, By Segmentation, 2022–2035

  2.3.1 Market Size By Product Type

  2.3.2 Market Size By Radioisotope

  2.3.3 Market Size By Application

  2.3.4 Market Size By End User

 2.4 Market Share & Bps Analysis By Region, 2025

 2.5 Industry Growth Scenarios – Conservative, Likely & Optimistic

 2.6 Industry CxO’s Perspective

3. Market Overview

 3.1 Market Dynamics

  3.1.1 Drivers

  3.1.2 Restraints

  3.1.3 Opportunities

  3.1.4 Key Market Trends

 3.2 Industry PESTLE Analysis

 3.3 Key Industry Forces (Porter’s) Impacting Market Growth

 3.4 Industry Supply Chain Analysis

  3.4.1 Raw Material Suppliers

  3.4.2 Manufacturers

  3.4.3 Distributors/Suppliers

  3.4.4 Customers/End-Users

 3.5 Industry Life Cycle Assessment

 3.6 Parent Market Overview

 3.7 Market Risk Assessment

4. Statistical Insights & Trends Reporting

     4.1 Adoption & Deployment Metrics

4.1.1 Percentage of nuclear medicine centers adopting theranostics for oncology vs. research purposes

4.1.2 Growth rate of theranostic adoption across hospitals and specialty cancer centers

4.1.3 Average number of theranostic procedures conducted per facility annually

     4.2 Platform & Technology Trends

4.2.1 Share of Lu-177 vs. Gallium-68 vs. Actinium-225 in total therapeutic radiopharmaceuticals

4.2.2 Percentage of theranostics integrated with PET/CT or SPECT imaging platforms

4.2.3 Rate of hospital in-house isotope production vs. external supply adoption

     4.3 Performance, Cost & Regulatory Statistics

4.3.1 Average treatment efficacy, patient response rate, and safety outcomes by radiopharmaceutical type

4.3.2 Share of theranostics approved under FDA, EMA, and other regulatory frameworks

4.3.3 Average cost per therapy dose and total treatment cycle

     4.4 User Adoption & Value Creation Insights

4.4.1 Average number of theranostic programs initiated per hospital annually

4.4.2 Percentage of specialty cancer centers using long-term supply agreements for Lu-177 or other isotopes

4.4.3 Clinical satisfaction, treatment reliability, and long-term patient outcome improvement metrics

5. Radiopharmaceutical Theranostics Market Segmental Analysis & Forecast, By Product Type, 2022 – 2035, Value (USD Billion)

5.1 Introduction

 5.2 Theranostic Pairs

  5.2.1 Key Trends

  5.2.2 Market Size & Forecast, 2022 – 2035

 5.3 Diagnostic Radiopharmaceuticals

 5.4 Therapeutic Radiopharmaceuticals

6. Radiopharmaceutical Theranostics Market Segmental Analysis & Forecast, By Radioisotope, 2022 – 2035, Value (USD Billion)

    6.1 Introduction

 6.2 Lutetium-177 (Lu-177)

  6.2.1 Key Trends

  6.2.2 Market Size & Forecast, 2022 – 2035

 6.3 Gallium-68 (Ga-68)

 6.4 Actinium-225

 6.5 Yttrium-90

 6.6 Iodine-131

7. Radiopharmaceutical Theranostics Market Segmental Analysis & Forecast, By Application, 2022 – 2035, Value (USD Billion)

    7.1 Introduction

 7.2 Oncology

  7.2.1 Key Trends

  7.2.2 Market Size & Forecast, 2022 – 2035

 7.3 Cardiology

 7.4 Neurology

8. Radiopharmaceutical Theranostics Market Segmental Analysis & Forecast, By End User, 2022 – 2035, Value (USD Billion)

    8.1 Introduction

 8.2 Hospitals

  8.2.1 Key Trends

  8.2.2 Market Size & Forecast, 2022 – 2035

 8.3 Specialty Cancer Centers

 8.4 Diagnostic Imaging Centers

9. Radiopharmaceutical Theranostics Market Segmental Analysis & Forecast By Region, 2022 – 2035, Value (USD Billion)

9.1 Introduction

9.2 North America

 9.2.1 Key Trends

 9.2.2 Radiopharmaceutical Theranostics Market Size & Forecast, By Product Type, 2022 – 2035

 9.2.3 Radiopharmaceutical Theranostics Market Size & Forecast, By Radioisotope, 2022 – 2035

 9.2.4 Radiopharmaceutical Theranostics Market Size & Forecast, By Application, 2022 – 2035

 9.2.5 Radiopharmaceutical Theranostics Market Size & Forecast, By End User, 2022 – 2035

 9.2.6 Radiopharmaceutical Theranostics Market Size & Forecast, By Country, 2022 – 2035

  9.2.6.1 USA

  9.2.6.2 Canada

9.3 Europe

 9.3.1 Key Trends

 9.3.2 Radiopharmaceutical Theranostics Market Size & Forecast, By Product Type, 2022 – 2035

 9.3.3 Radiopharmaceutical Theranostics Market Size & Forecast, By Radioisotope, 2022 – 2035

 9.3.4 Radiopharmaceutical Theranostics Market Size & Forecast, By Application, 2022 – 2035

 9.3.5 Radiopharmaceutical Theranostics Market Size & Forecast, By End User, 2022 – 2035

 9.3.6 Radiopharmaceutical Theranostics Market Size & Forecast, By Country, 2022 – 2035

  9.3.6.1 Germany

  9.3.6.2 UK

  9.3.6.3 France

  9.3.6.4 Italy

  9.3.6.5 Spain

  9.3.6.6 Russia

  9.3.6.7 Poland

  9.3.6.8 Rest of Europe

9.4 Asia-Pacific

 9.4.1 Key Trends

 9.4.2 Radiopharmaceutical Theranostics Market Size & Forecast, By Product Type, 2022 – 2035

 9.4.3 Radiopharmaceutical Theranostics Market Size & Forecast, By Radioisotope, 2022 – 2035

 9.4.4 Radiopharmaceutical Theranostics Market Size & Forecast, By Application, 2022 – 2035

 9.4.5 Radiopharmaceutical Theranostics Market Size & Forecast, By End User, 2022 – 2035

 9.4.6 Radiopharmaceutical Theranostics Market Size & Forecast, By Country, 2022 – 2035

  9.4.6.1 China

  9.4.6.2 India

  9.4.6.3 Japan

  9.4.6.4 South Korea

  9.4.6.5 Australia

  9.4.6.6 ASEAN Countries

  9.4.6.7 Rest of Asia-Pacific

9.5 Latin America

 9.5.1 Key Trends

 9.5.2 Radiopharmaceutical Theranostics Market Size & Forecast, By Product Type, 2022 – 2035

 9.5.3 Radiopharmaceutical Theranostics Market Size & Forecast, By Radioisotope, 2022 – 2035

 9.5.4 Radiopharmaceutical Theranostics Market Size & Forecast, By Application, 2022 – 2035

 9.5.5 Radiopharmaceutical Theranostics Market Size & Forecast, By End User, 2022 – 2035

 9.5.6 Radiopharmaceutical Theranostics Market Size & Forecast, By Country, 2022 – 2035

  9.5.6.1 Brazil

  9.5.6.2 Argentina

  9.5.6.3 Mexico

  9.5.6.4 Colombia

  9.5.6.5 Rest of Latin America

9.6 Middle East & Africa

 9.6.1 Key Trends

 9.6.2 Radiopharmaceutical Theranostics Market Size & Forecast, By Product Type, 2022 – 2035

 9.6.3 Radiopharmaceutical Theranostics Market Size & Forecast, By Radioisotope, 2022 – 2035

 9.6.4 Radiopharmaceutical Theranostics Market Size & Forecast, By Application, 2022 – 2035

 9.6.5 Radiopharmaceutical Theranostics Market Size & Forecast, By End User, 2022 – 2035

 9.6.6 Radiopharmaceutical Theranostics Market Size & Forecast, By Country, 2022 – 2035

  9.6.6.1 UAE

  9.6.6.2 Saudi Arabia

  9.6.6.3 Qatar

  9.6.6.4 Egypt

  9.6.6.5 South Africa

  9.6.6.6 Rest of Middle East & Africa

10. Competitive Landscape

 10.1 Key Players' Positioning

 10.2 Competitive Developments

  10.2.1 Key Strategies Adopted (%), By Key Players, 2025

  10.2.2 Year-Wise Strategies & Development, 2022 – 2035

  10.2.3 Number Of Strategies Adopted By Key Players, 2025

 10.3 Market Share Analysis, 2025

 10.4 Product/Service & Application Benchmarking

  10.4.1 Product/Service Specifications & Features By Key Players

  10.4.2 Product/Service Heatmap By Key Players

  10.4.3 Application Heatmap By Key Players

 10.5 Industry Start-Up & Innovation Landscape

10.6 Key Company Profiles

 10.6.1 Novartis AG

  10.6.1.1 Company Overview & Snapshot

  10.6.1.2 Product/Service Portfolio

  10.6.1.3 Key Company Financials

  10.6.1.4 SWOT Analysis

 10.6.2 Bayer AG

 10.6.3 GE HealthCare

 10.6.4 Bracco Imaging S.p.A.

 10.6.5 Curium Pharma

 10.6.6 Lantheus Holdings, Inc.

 10.6.7 Telix Pharmaceuticals Limited

 10.6.8 Eckert & Ziegler

 10.6.9 Cardinal Health, Inc.

 10.6.10 Nordion (Sotera Health Company)

 10.6.11 Isotopen Technologien München (ITM)

 10.6.12 Blue Earth Diagnostics  

 10.6.13 Theragnostics Ltd.

 10.6.14 NorthStar Medical Radioisotopes

 10.6.15 POINT Biopharma Global Inc.

 10.6.16 RadioMedix Inc.

 10.6.17 Fusion Pharmaceuticals

 10.6.18 BASF SE (radioisotope supply & materials support)

 10.6.19 IBA Radiopharma Solutions

 10.6.20 Siemens Healthineers

11. Analyst Recommendations

 11.1 SNS Insider Opportunity Map

 11.2 Industry Low-Hanging Fruit Assessment

 11.3 Market Entry & Growth Strategy

 11.4 Analyst Viewpoint & Suggestions on Market Growth

12. Assumptions

13. Disclaimer

14. Appendix

 14.1 List Of Tables

 14.2 List Of Figures